comparemela.com

Latest Breaking News On - Cardinal health trading - Page 8 : comparemela.com

Strs Ohio Sells 1,400 Shares of Cardinal Health, Inc (NYSE:CAH)

Strs Ohio lowered its holdings in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 4.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,647 shares of the company’s stock after selling 1,400 shares during the period. Strs Ohio’s […]

Cardinal Health, Inc (NYSE:CAH) Sees Large Increase in Short Interest

Cardinal Health, Inc. (NYSE:CAH – Free Report) was the recipient of a significant increase in short interest in June. As of June 15th, there was short interest totalling 8,970,000 shares, an increase of 52.8% from the May 31st total of 5,870,000 shares. Approximately 3.5% of the company’s stock are sold short. Based on an average […]

Octavia Wealth Advisors LLC Sells 146 Shares of Cardinal Health, Inc (NYSE:CAH)

Octavia Wealth Advisors LLC cut its position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 2.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,934 shares of the company’s stock after selling 146 shares during the quarter. Octavia Wealth Advisors […]

Citigroup Increases Cardinal Health (NYSE:CAH) Price Target to $90 00

Cardinal Health (NYSE:CAH – Get Rating) had its price target upped by equities researchers at Citigroup from $88.00 to $90.00 in a research report issued on Monday, The Fly reports. Citigroup’s price objective points to a potential upside of 2.25% from the company’s current price. Several other equities analysts have also commented on CAH. JPMorgan […]

Cardinal Health (NYSE:CAH) Price Target Raised to $97 00

Cardinal Health (NYSE:CAH – Get Rating) had its price objective upped by UBS Group from $93.00 to $97.00 in a research report issued to clients and investors on Sunday, The Fly reports. UBS Group’s target price would indicate a potential upside of 11.79% from the company’s current price. Other research analysts have also recently issued […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.